Zobrazeno 1 - 10
of 68
pro vyhledávání: '"E, Briassoulis"'
Autor:
Aristidis Polyzos, C. Christodoulou, Charalambos Kouroussis, George Fountzilas, Helen Gogas, E. Linardou, H. P. Kalofonos, E. Briassoulis, T. G. Iconomou, S. Chalkidou, Dimitris Bafaloukos, P. Panagiotou, Eleni Efstathiou, Dimosthenis Tsoutsos
Publikováno v:
Annals of Oncology. 16:950-957
Purpose: Temozolomide (TMZ) is an oral alkylating agent that produces methyl adducts at the 0.6 position of guanine. The methyl adducts are removed by the DNA repair enzyme AGAT. As demonstrated by in vitro studies, cisplatin (CDDP) is able to down-r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f0bc60e4cfe42cf15e1227809968911
https://doi.org/10.1093/annonc/mdi190
https://doi.org/10.1093/annonc/mdi190
Autor:
George Hatzitheoharis, Eleni Nenopoulou, Aris Bousoulegas, E. Briassoulis, George Basdanis, Urania Dafni, Nicholaos Karvounis, Christos Konstantaras, Paris Kosmidis, Eleftherios Giannoulis, Constantine Katsohis, John Dokmetzioglou, Alkis Zisiadis, Gerassimos Aravantinos, George Fountzilas, Spyros Papavramidis, Dimosthenis Skarlos, Nicholas Pavlidis
Publikováno v:
Oncology. 58:227-236
Background: It has been shown in randomized studies that adjuvant treatment with the combination of fluorouracil (FU) and levamisole reduced the risk of recurrence and deaths of patients with stage III colon cancer. Pharmacological studies of FU led
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2bfb39299c04013675da86c3f8e3eec2
https://doi.org/10.1159/000012105
https://doi.org/10.1159/000012105
Autor:
Epaminontas Samantas, D. Theocharis, Nicolas Tsavaris, Nicholas Pavlidis, G. Fountzilas, E. Briassoulis, D.V. Skarlos, P. Kosmidis
Publikováno v:
Journal of Clinical Oncology. 14:2682-2687
PURPOSE To investigate if double modulation of fluorouracil (5-FU) with leucovorin (folinic acid [FA]) and interferon alfa-2b (IFN 2b) improves responses and survival in comparison to single modulation of 5-FU with FA. PATIENTS AND METHODS One hundre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e619851b61e3d13384de7d2ea62bc21
https://doi.org/10.1200/jco.1996.14.10.2682
https://doi.org/10.1200/jco.1996.14.10.2682
Glutamine randomized studies in early life: The unsolved riddle of experimental and clinical studies
Glutamine may have benefits during immaturity or critical illness in early life but its effects on outcome end hardpoints are controversial. Our aim was to review randomized studies on glutamine supplementation in pups, infants, and children examinin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::9c9f776566f398db10ebc1b6b3ffcf00
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3002929
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3002929
Publikováno v:
Journal of Chemotherapy. 6:417-422
The main purpose of this trial was to investigate the activity of a less toxic regimen in patients with advanced gastric carcinoma regarding response rate and survival. We report on a pilot study of 20 patients treated with the combination of 5-fluor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb575e58e580b6316e16f560fb27ea42
https://doi.org/10.1080/1120009x.1994.11741177
https://doi.org/10.1080/1120009x.1994.11741177
Autor:
Achim Rody, Konstantine T. Kalogeras, George Fountzilas, Papadimitriou Ca, Anastasia G Eleftheraki, Isabell Witzel, E. Briassoulis, Volkmar Müller, Fritz Jänicke, Karin Milde-Langosch, D.G. Pectasides, Ralph M. Wirtz, M. Ihnen, Martina Schmidt
Publikováno v:
British Journal of Cancer
Background: To analyse the discriminative impact of osteopontin (OPN) and activated leukocyte cell adhesion molecule (ALCAM), combined with human epidermal growth factor 2 (HER2) and oestrogen receptor (ER) in breast cancer. Methods: Osteopontin, ALC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9366e8b86e04adbf8f3255829fa8bfe
https://pubmed.ncbi.nlm.nih.gov/20736952
https://pubmed.ncbi.nlm.nih.gov/20736952
Background & aims: Indirect calorimetry is commonly used for energy expenditure studies. However, older metabolic carts can be cumbersome and difficult to use. This study was aimed at validating the new M-COVX indirect calorimeter. Methods: This pros
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::fda088ad8f2ae61035e04984ce45068d
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3112733
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3112733
Purpose: Temozolomide (TMZ) is an oral alkylating agent that produces methyl adducts at the 0.6 position of guanine. The methyl adducts are removed by the DNA repair enzyme AGAT. As demonstrated by in vitro studies, cisplatin (CDDP) is able to down-r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::d6d7293830f1f9b1cff0ce4dec448218
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3094160
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3094160
Autor:
C. Kalofonos, Dimitra Gika, Christos Papadimitriou, Lia A. Moulopoulos, George Fountzilas, Meletios A. Dimopoulos, Gerassimos Aravantinos, E. Briassoulis
Publikováno v:
Gynecologic oncology. 92(1)
Objective. Patients with epithelial ovarian cancer (EOC) who relapse more than 6 months following completion of platinum-based primary chemotherapy are considered platinum-sensitive, and can be effectively retreated with cisplatin or carboplatin. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac51d784e4ba6f663a6c4e78ad975661
https://pubmed.ncbi.nlm.nih.gov/14751151
https://pubmed.ncbi.nlm.nih.gov/14751151
Autor:
D. Bafaloukos, H. Gogas, V. Georgoulias, E. Briassoulis, G. Fountzilas, E. Samantas, Ch. Kalofonos, D. Skarlos, A. Karabelis, P. Kosmidis
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 20(2)
PURPOSE: Temozolomide is a novel oral alkylating agent that is effective against melanoma. Moreover, temozolomide readily crosses the blood-brain barrier and may consequently be effective in patients with brain metastases. This phase II study was per
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::998b854551ed71423c41505ccc5f9085
https://pubmed.ncbi.nlm.nih.gov/11786569
https://pubmed.ncbi.nlm.nih.gov/11786569